Phreesia, Inc. (NYSE: PHR) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $780M. The Maz Rating grades it against the other companies in its sector.
Phreesia, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $12.56, Phreesia, Inc. trades at 72.9x trailing earnings, 1.5x sales and 2.1x book value, with an EV/EBITDA of 13.8. Over the last twelve months it generated about $508M of revenue and $11M of net income. It runs a gross margin of 63.5%, an operating margin of 3.2% and a net margin of 2.1%. It shows return on equity of 3.0%, return on invested capital of 3.2% and a free cash flow yield of 9.9%. On the balance sheet: a debt-to-equity ratio of 0.18 and a current ratio of 1.76. Over the past 52 weeks the share price ranged from $7.77 to $21.24, with a beta of 0.84.
Phreesia, Inc. does not currently pay a dividend.
26 Wall Street analyst ratings cover the stock: 18 Buy, 7 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.